AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
The transaction consists of AngioDynamics’ PICC, Midline and tip location products.
- The transaction consists of AngioDynamics’ PICC, Midline and tip location products.
- This combined portfolio of products contributed approximately $43.5 million in annual sales during AngioDynamics’ fiscal year 2023.
- These products contributed approximately $5.5 million in annual sales during AngioDynamics’ fiscal year 2023.
- The divestiture of the PICC and Midline businesses, together with the discontinuance of the radiofrequency ablation and Syntrax businesses, will reduce full-year fiscal 2024 revenue by approximately $50 million.